Joseph T Tomita

Title: Joseph T Tomita: Innovator in Carcinoembryonic Antigen Assays

Introduction

Joseph T Tomita is a notable inventor based in Waukegan, IL (US). He has made significant contributions to the field of immunoassays, particularly in the detection of carcinoembryonic antigen (CEA). With a total of 2 patents, his work has advanced the methodologies used in medical diagnostics.

Latest Patents

Tomita's latest patents include the "Antibody adsorbed support method for carcinoembryonic antigen assay." This invention relates to an immunoassay for carcinoembryonic antigen in plasma or sera. The method involves heat-treating the plasma or serum to produce a supernatant, which is then incubated with a solid support that has carcinoembryonic antigen antibody adsorbed onto it. Following this, the solid support is incubated with a labeled carcinoembryonic antigen antibody, and the labeled antibody on the solid support is measured and compared to standards. Another significant patent is the "Pretreatment method for carcinoembryonic antigen assay." This patent discloses an improvement in the method for separating carcinoembryonic antigen from a plasma sample, which is essential for conducting an assay for the antigen.

Career Highlights

Joseph T Tomita is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on innovative solutions that enhance diagnostic accuracy and efficiency.

Collaborations

Tomita has collaborated with notable colleagues, including Yung D Kim and Jay R Schenck. These collaborations have contributed to the development of advanced methodologies in the field of immunoassays.

Conclusion

Joseph T Tomita's contributions to the field of carcinoembryonic antigen assays demonstrate his commitment to innovation in medical diagnostics. His patents reflect a deep understanding of immunoassay techniques, which have the potential to improve patient outcomes.